The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132327 · Cited by 2,653
Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
Morgan, D. A., Ruscetti, F. W., & Gallo, R. (1976) · Science · doi:10.1126/science.181845 · Cited by 2,493
Interleukin-2: Inception, Impact, and Implications
Smith, K. A. (1988) · Science · doi:10.1126/science.3131876 · Cited by 2,153
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,820
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
The role of interleukin-2 during homeostasis and activation of the immune system
Boyman, O., & Sprent, J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3156 · Cited by 1,657
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.009 · Cited by 1,507
Foxp3+ follicular regulatory T cells control the germinal center response
Linterman, M. A., Pierson, W., Lee, S. K., Kallies, A., Kawamoto, S., Rayner, T. F., Srivastava, M., Divekar, D. P., Beaton, L., Hogan, J. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2425 · Cited by 1,292
IL-2: The First Effective Immunotherapy for Human Cancer
Rosenberg, S. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1490019 · Cited by 1,289
Setoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,235
Structure and expression of a cloned cDNA for human interleukin-2
Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R., & Hamuro, J. (1983) · Nature · doi:10.1038/302305a0 · Cited by 1,182
Rosenberg, S. A. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510360033032 · Cited by 1,131
Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions
Chung, Y., Tanaka, S., Chu, F., Nurieva, R. I., Martinez, G. J., Rawal, S., Wang, Y.-H., Lim, H., Reynolds, J. M., Zhou, X.-H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2426 · Cited by 1,120
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
Natural regulatory T cells control the development of atherosclerosis in mice
Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,100
Self-citationInterleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,080
Malek, T. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090357 · Cited by 1,079
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Liao, W., Lin, J.-X., & Leonard, W. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.01.004 · Cited by 1,075
Eosinophils: changing perspectives in health and disease
Rosenberg, H. F., Dyer, K. D., & Foster, P. S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3341 · Cited by 989
Th17 and regulatory T cell balance in autoimmune and inflammatory diseases
Noack, M., & Miossec, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.12.004 · Cited by 932
Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β
Suzuki, H., Kündig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J. J. L., Ohashi, P. S., Griesser, H., et al. (1995) · Science · doi:10.1126/science.7770771 · Cited by 871
Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes
Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D., & Sprent, J. (2006) · Science · doi:10.1126/science.1122927 · Cited by 870
Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells
Williams, M. A., Tyznik, A. J., & Bevan, M. J. (2006) · Nature · doi:10.1038/nature04790 · Cited by 797
Pipkin, M. E., Sacks, J. A., Cruz-Guilloty, F., Lichtenheld, M. G., Bevan, M. J., & Rao, A. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.012 · Cited by 795
Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer
Yang, J. C., Sherry, R. M., Steinberg, S. M., Topalian, S. L., Schwartzentruber, D. J., Hwu, P., Seipp, C. A., Rogers-Freezer, L., Morton, K. E., White, D. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.122 · Cited by 790
CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rβ-Deficient Mice
Malek, T. R., Yu, A., Vincek, V., Scibelli, P., & Kong, L. (2002) · Immunity · doi:10.1016/s1074-7613(02)00367-9 · Cited by 779
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D., Cacoub, P., & Klatzmann, D. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105143 · Cited by 762
Self-citationOhkura, N., Hamaguchi, M., Morikawa, H., Sugimura, K., Tanaka, A., Ito, Y., Osaki, M., Tanaka, Y., Yamashita, R., Nakano, N., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.010 · Cited by 754
Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A., Salomon, B. L., & Bluestone, J. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.016 · Cited by 729
Oliphant, C. J., Hwang, Y. Y., Walker, J. A., Salimi, M., Wong, S. H., Brewer, J. M., Englezakis, A., Barlow, J. L., Hams, E., Scanlon, S. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.016 · Cited by 696
IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
Ahmadzadeh, M., & Rosenberg, S. A. (2006) · Blood · doi:10.1182/blood-2005-06-2399 · Cited by 632
tTregs, pTregs, and iTregs: similarities and differences
Shevach, E. M., & Thornton, A. M. (2014) · Immunological Reviews · doi:10.1111/imr.12160 · Cited by 606
Regulation of the Germinal Center Reaction by Foxp3+ Follicular Regulatory T Cells
Wollenberg, I., Agua-Doce, A., Hernández, A., Almeida, C., Oliveira, V. G., Faro, J., & Graca, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101328 · Cited by 599
Kalia, V., Sarkar, S., Subramaniam, S., Haining, W. N., Smith, K. A., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.010 · Cited by 587
Induced CD4+Foxp3+Regulatory T Cells in Immune Tolerance
Bilate, A. M., & Lafaille, J. J. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075043 · Cited by 569
D’Alessio, F. R., Tsushima, K., Aggarwal, N. R., West, E. E., Willett, M. H., Britos, M. F., Pipeling, M. R., Brower, R. G., Tuder, R. M., McDyer, J. F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36498 · Cited by 564
Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
Levin, A. M., Bates, D. L., Ring, A. M., Krieg, C., Lin, J. T., Su, L., Moraga, I., Raeber, M. E., Bowman, G. R., Novick, P., et al. (2012) · Nature · doi:10.1038/nature10975 · Cited by 552
Ballesteros-Tato, A., León, B., Graf, B. A., Moquin, A., Adams, P. S., Lund, F. E., & Randall, T. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.02.012 · Cited by 542
The plasticity and stability of regulatory T cells
Sakaguchi, S., Vignali, D. A. A., Rudensky, A. Y., Niec, R. E., & Waldmann, H. (2013) · Nature Reviews Immunology · doi:10.1038/nri3464 · Cited by 525
Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells
Roediger, B., Kyle, R., Yip, K. H., Sumaria, N., Guy, T. V., Kim, B. S., Mitchell, A. J., Tay, S. S., Jain, R., Forbes-Blom, E., et al. (2013) · Nature Immunology · doi:10.1038/ni.2584 · Cited by 492
Liao, W., Lin, J.-X., Wang, L., Li, P., & Leonard, W. J. (2011) · Nature Immunology · doi:10.1038/ni.2030 · Cited by 474
Matsuoka, K.-I., Koreth, J., Kim, H. T., Bascug, G., McDonough, S., Kawano, Y., Murase, K., Cutler, C., Ho, V. T., Alyea, E. P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005265 · Cited by 468
Grinberg-Bleyer, Y., Baeyens, A., You, S., Elhage, R., Fourcade, G., Gregoire, S., Cagnard, N., Carpentier, W., Tang, Q., Bluestone, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100209 · Cited by 433
Self-citationMarek-Trzonkowska, N., Myśliwiec, M., Dobyszuk, A., Grabowska, M., Techmańska, I., Juścińska, J., Wujtewicz, M. A., Witkowski, P., Młynarski, W., Balcerska, A., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0038 · Cited by 431
Hartemann, A., Bensimon, G., Payan, C. A., Jacqueminet, S., Bourron, O., Nicolas, N., Fonfrede, M., Rosenzwajg, M., Bernard, C., & Klatzmann, D. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70113-x · Cited by 428
Self-citationControl of the Inheritance of Regulatory T Cell Identity by a cis Element in the Foxp3 Locus
Feng, Y., Arvey, A., Chinen, T., van der Veeken, J., Gasteiger, G., & Rudensky, A. Y. (2014) · Cell · doi:10.1016/j.cell.2014.07.031 · Cited by 422
Interleukin 2 plays a central role in Th2 differentiation
Cote-Sierra, J., Foucras, G., Guo, L., Chiodetti, L., Young, H. A., Hu-Li, J., Zhu, J., & Paul, W. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400339101 · Cited by 420
Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor
Sharfe, N., Dadi, H. K., Shahar, M., & Roifman, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3168 · Cited by 409
Smigiel, K. S., Richards, E., Srivastava, S., Thomas, K. R., Dudda, J. C., Klonowski, K. D., & Campbell, D. J. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131142 · Cited by 405
Lotze, M. T., Frana, L. W., Sharrow, S. O., Robb, R. J., & Rosenberg, S. A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.1.157 · Cited by 388
Krieg, C., Létourneau, S., Pantaleo, G., & Boyman, O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002569107 · Cited by 380
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells
Zhang, H., Chua, K. S., Guimond, M., Kapoor, V., Brown, M. V., Fleisher, T. A., Long, L. M., Bernstein, D., Hill, B. J., Douek, D. C., et al. (2005) · Nature Medicine · doi:10.1038/nm1312 · Cited by 377
Interleukin 2: the molecule and its function
Robb, R. J. (1984) · Immunology Today · doi:10.1016/0167-5699(84)90224-x · Cited by 362
X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.
Godfrey, V., Wilkinson, J. E., & Russell, L. B. (1991) · PubMed · Cited by 337
Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza
London, N. R., Zhu, W., Bozza, F. A., Smith, M. C. P., Greif, D. M., Sorensen, L. K., Chen, L., Kaminoh, Y., Chan, A. C., Passi, S. F., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000678 · Cited by 330
van Loosdregt, J., Fleskens, V., Fu, J., Brenkman, A. B., Bekker, C. P. J., Pals, C. E. G. M., Meerding, J., Berkers, C. R., Barbi, J., Gröne, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.018 · Cited by 317
Chen, Z., Barbi, J., Bu, S., Yang, H.-Y., Li, Z., Gao, Y., Jinasena, D., Fu, J., Lin, F., Chen, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.006 · Cited by 304
Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells
Bensinger, S. J., Walsh, P. T., Zhang, J., Carroll, M., Parsons, R., Rathmell, J. C., Thompson, C. B., Burchill, M. A., Farrar, M. A., & Turka, L. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5287 · Cited by 289
Identification of CD8 + CD25 + Foxp3 + suppressive T cells in colorectal cancer tissue
Chaput, N., Louafi, S., Bardier, A., Charlotte, F., Vaillant, J.-C., Ménégaux, F., Rosenzwajg, M., Lemoine, F., Klatzmann, D., & Taieb, J. (2009) · Gut · doi:10.1136/gut.2008.158824 · Cited by 264
Self-citationYu, A., Zhu, L., Altman, N. H., & Malek, T. R. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.014 · Cited by 263
Vang, K. B., Yang, J., Mahmud, S. A., Burchill, M. A., Vegoe, A. L., & Farrar, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3285 · Cited by 262
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Rosenzwajg, M., Churlaud, G., Mallone, R., Six, A., Dérian, N., Chaara, W., Lorenzon, R., Long, S. A., Buckner, J. H., Afonso, G., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.01.001 · Cited by 257
Self-citationRegulatory T cells suppress muscle inflammation and injury in muscular dystrophy
Villalta, S. A., Rosenthal, W., Martinez, L., Kaur, A., Sparwasser, T., Tidball, J. G., Margeta, M., Spencer, M. J., & Bluestone, J. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009925 · Cited by 254
Zheng, X. X., Sánchez-Fueyo, A., Sho, M., Domenig, C., Sayegh, M. H., & Strom, T. B. (2003) · Immunity · doi:10.1016/s1074-7613(03)00259-0 · Cited by 248
Yamaguchi, T., Wing, J. B., & Sakaguchi, S. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.10.002 · Cited by 236
Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Castela, E., Le Duff, F., Butori, C., Ticchioni, M., Hofman, P., Bahadoran, P., Lacour, J.-P., & Passeron, T. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.504 · Cited by 229
Boyer, O., Saadoun, D., Abriol, J., Dodille, M., Piette, J.-C., Cacoub, P., & Klatzmann, D. (2004) · Blood · doi:10.1182/blood-2003-07-2598 · Cited by 223
Self-citationCytokine dysregulation as a mechanism of graft versus host disease
Ferrara, J. L. M. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90139-j · Cited by 222
Cutting Edge: Mechanisms of IL-2–Dependent Maintenance of Functional Regulatory T Cells
Barron, L., Dooms, H., Hoyer, K. K., Kuswanto, W., Hofmann, J., O’Gorman, W. E., & Abbas, A. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903940 · Cited by 219
Self-citationHuman and Mouse CD8+CD25+FOXP3+ Regulatory T Cells at Steady State and during Interleukin-2 Therapy
Churlaud, G., Pitoiset, F., Jebbawi, F., Lorenzon, R., Bellier, B., Rosenzwajg, M., & Klatzmann, D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00171 · Cited by 203
Self-citationKennedy-Nasser, A. A., Ku, S., Castillo-Caro, P., Hazrat, Y., Wu, M.-F., Liu, H., Melenhorst, J., Barrett, A. J., Ito, S., Foster, A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3205 · Cited by 201
Schultz, M., Tonkonogy, S. L., Sellon, R. K., Veltkamp, C., Godfrey, V. L., Kwon, J., Grenther, W. B., Balish, E., Horak, I., & Sartor, R. B. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.6.g1461 · Cited by 200
Yu, A., Snowhite, I., Vendrame, F., Rosenzwajg, M., Klatzmann, D., Pugliese, A., & Malek, T. R. (2015) · Diabetes · doi:10.2337/db14-1322 · Cited by 197
Self-citationKaufman, H. L., Kirkwood, J. M., Hodi, F. S., Agarwala, S., Amatruda, T., Bines, S. D., Clark, J. I., Curti, B., Ernstoff, M. S., Gajewski, T., et al. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.153 · Cited by 196
Contractor, N. V., Bassiri, H., Reya, T., Park, A. Y., Baumgart, D. C., Wasik, M. A., Emerson, S. G., & Carding, S. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.385 · Cited by 180
Dinh, T. N., Kyaw, T. S., Kanellakis, P., To, K., Tipping, P., Toh, B.-H., Bobik, A., & Agrotis, A. (2012) · Circulation · doi:10.1161/circulationaha.112.099044 · Cited by 170
PTEN inhibits IL-2 receptor-mediated expansion of CD4+CD25+ Tregs
Walsh, P. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28057 · Cited by 164
Gratz, I. K., Truong, H.-A., Yang, S. H.-Y., Maurano, M. M., Lee, K., Abbas, A. K., & Rosenblum, M. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300212 · Cited by 161
Self-citationLiao, W., Spolski, R. J., Li, P., Du, N., West, E. E., Ren, M., Mitra, S., & Leonard, W. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301138111 · Cited by 161
Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
Humrich, J. Y., von Spee-Mayer, C., Siegert, E., Alexander, T., Hiepe, F., Radbruch, A., Burmester, G.-R., & Riemekasten, G. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206506 · Cited by 161
The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity
Lieberman, L. A., & Tsokos, G. C. (2010) · BioMed Research International · doi:10.1155/2010/740619 · Cited by 158
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (2011) · PubMed · Cited by 150
Gutierrez‐Ramos, J. C., Andreu, J. L., Revilla, Y., Viñuela, E., & Martínez-A, C. (1990) · Nature · doi:10.1038/346271a0 · Cited by 136
Shanafelt, A. B., Lin, Y., Shanafelt, M.-C., Forte, C. P., Dubois‐Stringfellow, N., Carter, C., Gibbons, J. A., Cheng, S.-L., Delaria, K. A., Fleischer, R., et al. (2000) · Nature Biotechnology · doi:10.1038/81199 · Cited by 135
Ribot, J. C., Ribeiro, S. T., Correia, D. V., Sousa, A. E., & Silva‐Santos, B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303119 · Cited by 129
Gool, F. V., Molofsky, A. B., Morar, M. M., Rosenzwajg, M., Liang, H.-E., Klatzmann, D., Locksley, R. M., & Bluestone, J. A. (2014) · Blood · doi:10.1182/blood-2014-07-587493 · Cited by 128
Self-citationLi, Z., Lin, F., Zhuo, C., Deng, G., Chen, Z., Yin, S., Gao, Z., Piccioni, M., Tsun, A., Cai, S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.586651 · Cited by 122
Ito, S., Bollard, C. M., Carlsten, M., Melenhorst, J. J., Biancotto, A., Wang, E., Chen, J., Kotliarov, Y., Cheung, F., Xie, Z., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.50 · Cited by 117
Decreased Synthesis of Interleukin-2 (IL-2) in Insulin-dependent Diabetes Mellitus
Zier, K. S., Leo, M. M., Spielman, R. S., & Baker, L. (1984) · Diabetes · doi:10.2337/diab.33.6.552 · Cited by 117
Mizui, M., Koga, T., Lieberman, L. A., Beltrán, J., Yoshida, N., Johnson, M. C., Tisch, R., & Tsokos, G. C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400977 · Cited by 116
Expansion of regulatory T cells via IL‐2/anti‐IL‐2 mAb complexes suppresses experimental myasthenia
Liu, R., Zhou, Q., Cava, A. L., Campagnolo, D. I., Kaer, L. V., & Shi, F. (2010) · European Journal of Immunology · doi:10.1002/eji.200939792 · Cited by 116
Primary Immune Deficiency Disorders Presenting as Autoimmune Diseases: IPEX and APECED
Vasconcelos, D. D. M., Costa-Carvalho, B. T., Torgerson, T. R., & Ochs, H. D. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9176-5 · Cited by 112
Wilson, M. S., Pesce, J. T., Ramalingam, T. R., Thompson, R. W., Cheever, A. W., & Wynn, T. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6942 · Cited by 111
The narrowing of the CD8 T cell repertoire in old age
Blackman, M. A., & Woodland, D. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.05.005 · Cited by 110
Weiss, L., Letimier, F. A., Carrière, M., Maiella, S., Donkova-Petrini, V., Targat, B., Benecke, A., Rogge, L., & Lévy, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000027107 · Cited by 97
Regulatory and Effector T Cell Activation Levels Are Prime Determinants of In Vivo Immune Regulation
Billiard, F., Litvinova, E., Saadoun, D., Djelti, F., Klatzmann, D., Cohen, J. L., Marodon, G., & Salomon, B. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2167 · Cited by 82
Self-citationRe-establishing immunological self-tolerance in autoimmune disease
Sakaguchi, S., Powrie, F. M., & Ransohoff, R. M. (2012) · Nature Medicine · doi:10.1038/nm.2622 · Cited by 79
Hao, J., Campagnolo, D. I., Liu, R., Piao, W., Shi, S. X.-Y., Hu, B., Xiang, R., Zhou, Q., Vollmer, T. L., Kaer, L. V., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22339 · Cited by 78
Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells
Dietrich, T., Hucko, T., Schneemann, C., Neumann, M., Menrad, A., Willuda, J., Atrott, K., Stibenz, D., Fleck, E., Graf, K., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.050 · Cited by 76
IL-15 Fosters Age-Driven Regulatory T Cell Accrual in the Face of Declining IL-2 Levels
Raynor, J. L., Sholl, A., Plas, D. R., Bouillet, P., Chougnet, C. A., & Hildeman, D. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00161 · Cited by 74
Churlaud, G., Jiménez, V., Ruberte, J., Zin, M. A., Fourcade, G., Gottrand, G., Casana, E., Lambrecht, B., Bellier, B., Piaggio, E., et al. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.02.003 · Cited by 66
Self-citationMeCP2 enforces Foxp3 expression to promote regulatory T cells’ resilience to inflammation
Li, C.-R., Jiang, S., Liu, S.-Q., Lykken, E. A., Zhao, L., Sevilla, J., Zhu, B., & Li, Q.-J. (2014) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1401505111 · Cited by 60
Lemoine, F. M. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000368 · Cited by 55
Rouse, M. D., Nagarkatti, M., & Nagarkatti, P. S. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.269 · Cited by 45
Landau, D. A., Rosenzwajg, M., Saadoun, D., Trebeden‐Negre, H., Klatzmann, D., & Cacoub, P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23759 · Cited by 42
Self-citationMack, D. G., Falta, M. T., McKee, A. S., Martin, A. D., Simonian, P. L., Crawford, F., Gordon, T., Mercer, R. R., Hoover, M. D., Marrack, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408048111 · Cited by 41
Inducible Adeno-Associated Virus-Mediated IL-2 Gene Therapy Prevents Autoimmune Diabetes
Goudy, K., Johnson, M. C., Garland, A. L., Li, C., Samulski, R. J., Wang, B., & Tisch, R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001422 · Cited by 37
Cited by
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
“Accordingly, low-dose IL-2 therapy for autoimmune and inflammatory diseases is under development (199).”
BackgroundChaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx108 · Cited by 1,310
Periodontitis: facts, fallacies and the future
Slots, J. (2017) · Periodontology 2000 · doi:10.1111/prd.12221 · Cited by 1,153
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
Revisiting IL-2: Biology and therapeutic prospects
Abbas, A. K., Trotta, E., R. Simeonov, D., Marson, A., & Bluestone, J. A. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat1482 · Cited by 636
Self-citation
Metadata
- Authors
- Klatzmann, D., & Abbas, A. K.
- Venue
- Nature Reviews Immunology
- Published
- 2015-04-17
- Volume
- 15
- Issue
- 5
- Pages
- 283-294
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1970246068
- Cited by
- 636
- References
- 112
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.